Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis

BACKGROUND: Efficacy and safety data of COVID-19 vaccines among cancer populations have been limited; however, preliminary data from recent studies have emerged regarding their immunogenicity and safety in this population. In this review, we examined current peer-reviewed publications containing ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Son, Truong, Tony H., Narendran, Aru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542448/
https://www.ncbi.nlm.nih.gov/pubmed/34798454
http://dx.doi.org/10.1016/j.ejca.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542448/
https://www.ncbi.nlm.nih.gov/pubmed/34798454
http://dx.doi.org/10.1016/j.ejca.2021.10.013

Ejemplares similares